[Chronic myelocytic leukemia. Is the insufficient treatment at the terminal stage a reason for changing therapeutical tactics of the chronic phase?]

Vnitr Lek. 1974 Sep;20(8):741-5.
[Article in Slovak]
No abstract available

Publication types

  • English Abstract

MeSH terms

  • Antibody Formation
  • Antineoplastic Agents / therapeutic use*
  • Evaluation Studies as Topic
  • Humans
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / immunology
  • Remission, Spontaneous

Substances

  • Antineoplastic Agents